WALTHAM, Mass. - Morphic Therapeutic (NASDAQ:MORF), a biopharmaceutical company, announced Monday the appointment of Simon Cooper, M.B.B.S., as its new Chief Medical Officer. Dr. Cooper, recognized ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results